Back
ESC Premium Access

Tissue Doppler E prime velocity and E/E prime predict 19-year cardiovascular mortality in hypertension

Session: Congress committee e-posters choice in hypertension
Topic: Epidemiology, Prognosis, Outcome
Speaker: Doctor A. Ratneswaren (Greater London, GB)
Event: ESC Congress 2021 - The Digital Experience

Congress Presentation

0

About the speaker

Doctor Anenta Ratneswaren

St Georges Hospital, Greater London (United Kingdom of Great Britain & Northern Ireland)
1 presentation
0 follower

5 more presentations in this session

Hypertensive heart disease burden attributable to high salt intake in the United States compared to the European Union and the global status: trends from 1990 to 2019

Speaker: Ms Z. Aryan (Boston, US)

Access
Abstract
Slides
0
Thumbnail

Effect of the renin angiotensin system inhibitors on inflammatory markers: a systematic review and meta-analysis of 32 randomized controlled trials.

Speaker: Professor M. Banach (Lodz, PL)

Access
Abstract
Slides
0
Thumbnail

"Stifflammation" in hypertension is a predictor of future cardiovascular hospitalizations

Speaker: Doctor G. Christopoulou (Dafni-Ymittos, GR)

Access
Abstract
Slides
0
Thumbnail

Arterial stiffness in adolescence predicts elevated blood pressure in young adulthood: The ALSPAC study

Speaker: Doctor A. Agbaje (Kuopio, FI)

Access
Abstract
Slides
0
Thumbnail

Blood pressure control in the general and high risk populations, longitudinal trends.

Speaker: Associate Professor J. Bruthans (Prague, CZ)

Access
Abstract
Slides
0
Thumbnail

Access the full session

Congress committee e-posters choice in hypertension

Speakers: Doctor A. Ratneswaren, Ms Z. Aryan, Professor M. Banach, Doctor G. Christopoulou, Doctor A. Agbaje...
Access
0
Thumbnail

About the event

Image

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Congress
logo Image

Related content

ESC Premium Access

Blood pressure control in the general and high risk populations, longitudinal trends.

27 August 2021

ESC Premium Access

24-month results and technical approach of catheter-based renal denervation in patients with resistant hypertension

27 August 2021

ESC Premium Access

Cardiovascular protection by combination of the selective nonsteroidal MR antagonist finerenone and the SGLT2 inhibitor empagliflozin in a preclinical model of hypertension-induced end-organ damage

27 August 2021

ESC 365 is supported by

logo Novo Nordisk